ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 105 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,756,000 | +166.9% | 100,000 | +274.5% | 0.21% | -24.7% |
| Q4 2017 | $658,000 | -68.7% | 26,700 | -67.2% | 0.28% | -64.9% |
| Q3 2017 | $2,104,000 | +69.7% | 81,500 | +78.2% | 0.80% | +51.9% |
| Q2 2017 | $1,240,000 | -9.1% | 45,740 | 0.0% | 0.52% | -4.4% |
| Q1 2017 | $1,364,000 | -60.3% | 45,740 | -63.9% | 0.55% | -67.3% |
| Q4 2016 | $3,439,000 | +402.8% | 126,700 | +374.5% | 1.67% | +594.6% |
| Q3 2016 | $684,000 | -38.3% | 26,700 | -55.5% | 0.24% | -86.2% |
| Q2 2016 | $1,108,000 | – | 60,000 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |